The Trump administration struck deals with pharmaceutical companies Novo Nordisk and Eli Lilly to lower prices and copays for type 2 diabetes and obesity drugs --- but not everyone will qualify.
Copyright 2025 NPR
© 2025 Public Radio Tulsa
800 South Tucker Drive
Tulsa, OK 74104
(918) 631-2577
A listener-supported service of The University of Tulsa
800 South Tucker Drive
Tulsa, OK 74104
(918) 631-2577
A listener-supported service of The University of Tulsa
classical 88.7 | public radio 89.5
Play Live Radio
Next Up:
0:00
0:00
Available On Air Stations